US 12215105
HPK1 antagonists and uses thereof
granted A61PA61P31/00A61P35/00
Quick answer
US patent 12215105 (HPK1 antagonists and uses thereof) held by Nimbus Saturn, Inc. expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Nimbus Saturn, Inc.
- Grant date
- Tue Feb 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61P, A61P31/00, A61P35/00